Grants for Independent school districts - Federal

This funding opportunity provides financial support to organizations working in Botswana to strengthen health data systems and improve the government-led response to HIV, TB, and related public health threats through enhanced surveillance and digital health initiatives.

The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) is a funding opportunity designed to support early-stage health professionals who are dedicated to aging and aging-related diseases research, helping them enhance their research and leadership skills, establish independent research programs, and prepare to lead in their field to improve health outcomes for older individuals.

This funding opportunity supports research institutions and organizations in developing a comprehensive study on viral respiratory infections in young children, aiming to improve understanding and treatment of these common illnesses.

The URGenT network grant aims to speed up the development and clinical testing of gene-based therapies for ultra-rare neurological or neuromuscular disorders, with the ultimate goal of initiating a clinical trial.

This funding opportunity supports researchers in exploring brain imaging techniques related to substance use and addiction, providing resources for small studies that can lead to larger research projects.

This funding opportunity provides financial support to various organizations to strengthen Sierra Leone's public health systems, focusing on disease prevention, detection, and response capabilities.

The Office of Refugee Resettlement (ORR) within the Administration for Children and Families (ACF) announces funding under the Refugee Family Child Care Microenterprise Development Project (RFCCMED). Through the RFCCMED program, ORR will fund successful applicants to provide refugee participants with training and technical assistance in professional child care, microenterprise development, and financial literacy; assist refugee participants in navigating the child care licensing process; and provide direct financial assistance as needed to enable participants to prepare their homes for child care business operation. Successful applicants will demonstrate internal capacity and partnerships to provide program services. The three main objectives of RFCCMED are to 1) help refugees to achieve economic self-sufficiency by establishing licensed family child care (FCC) businesses; 2) help refugee families gain access to licensed FCC businesses which will meet the early care and developmental needs of refugee children; and 3) assist refugees in learning how to navigate mainstream child care services.

This funding opportunity supports interdisciplinary teams in developing innovative tools to measure and analyze human behavior in real-world settings, integrating neural and environmental data to advance our understanding of brain function and behavior.

This funding opportunity supports research projects that utilize existing datasets to advance understanding of substance use disorders, targeting a wide range of eligible applicants including educational institutions, government entities, and nonprofits.

This funding opportunity supports innovative research projects aimed at improving burn care for military personnel, particularly in combat situations, by addressing unique medical challenges and enhancing treatment methods.

This funding opportunity provides financial support to early-stage postdoctoral researchers dedicated to advancing their careers in cancer research through enhanced training and mentorship.

This funding opportunity provides financial support for established neuroscientists to extend their research projects, ensuring continuity and progress in the field of neurological disorders.

This Notice of Funding Opportunity (NOFO) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the National Institute on Deafness and Other Communication Disorders (NIDCD). This program is intended to support Early Stage and New Investigators from diverse backgrounds, including those from groups underrepresented in the health-related sciences. Investigators from diverse backgrounds, including those from underrepresented groups (e.g., seeNOT-OD-20-031, Notice of NIHs Interest in Diversity), are eligible to apply. Investigators from categories A-C are particularly encouraged to work with their institutions to apply. Preliminary data are not required for this NOFO. All applications require a letter of affirmation from the applicant institution documenting the Investigators eligibility. Applications that do not include this letter will be administratively withdrawn.

This funding opportunity provides support for organizations to create safe living environments and essential services for pregnant and parenting youth facing homelessness or housing instability across the United States.

This funding opportunity supports U.S.-based researchers and organizations in discovering and developing natural products as potential agents for cancer prevention, focusing on safe and effective compounds.

This funding opportunity supports innovative research to personalize probiotic therapies by identifying individual factors that influence how people respond to probiotics, ultimately aiming to improve health outcomes.

The F25AS00011 - NAWCA 2025 U.S. Small Grants program is a competitive funding opportunity that supports partnerships focused on long-term protection, restoration, and enhancement of wetland and associated habitats for migratory birds in the United States, requiring a 1:1 non-federal match and excluding research funding.

This funding opportunity supports innovative research projects aimed at improving health outcomes and reducing disparities for minority populations in the U.S. through short-term studies and pilot interventions.

This funding opportunity provides financial support to U.S. institutions focused on improving minority health and reducing health disparities by enhancing research capacity, fostering investigator development, and promoting community engagement.

The U.S. Food and Drug Administration (FDA) seeks applications to develop, implement, and evaluate a human abuse potential (HAP) study of botanical Kratom. FDA has previously warned consumers about the use of Kratom (Mitragyna speciosa), a plant indigenous to Southeast Asia. Kratom alkaloids have demonstrated both affinity and activity at receptor sites known to be associated with abuse, such as mu opioid receptors. Although Kratom use is prevalent, to date, clinical evaluations of its abuse potential have been limited. The proposed HAP study should be performed in accordance with the guidance for industry, "Assessment of Abuse Potential of Drugs," including (but not limited to) the selection of an appropriate comparator(s) and outcome measures, statistical analyses etc. Interested parties, will also complete the submission of an Investigational New Drug (IND) application and obtain Institutional Review Board (IRB) clearance.